Cargando…
Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)
Tumor multidrug resistance (MDR) remains one of the most challenging barriers to successful cancer treatment. Several previous studies have suggested that high mobility group box 1 (HMGB1) may be a promising therapeutic target for overcoming cancer drug resistance. Emerging evidence has indicated th...
Autores principales: | Shao, Li-Hua, Zhu, Li, Wang, Meng, Ning, Yue, Chen, Feng-Qin, Gao, Xia-Qing, Yang, Chun-Ting, Wang, Hong-Wei, Li, Hai-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373125/ https://www.ncbi.nlm.nih.gov/pubmed/37387415 http://dx.doi.org/10.3892/ijmm.2023.5272 |
Ejemplares similares
-
HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021) -
Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis
por: Wang, Chao-Qun, et al.
Publicado: (2020) -
Lysosome-associated protein transmembrane4β is involved in multidrug resistance processes of colorectal cancer
por: Huang, Yue-Nan, et al.
Publicado: (2017) -
HMGB1 Translocation is Associated with Tumor-Associated Myeloid Cells and Involved in the Progression of Fibroblastic Sarcoma
por: Chen, Huoying, et al.
Publicado: (2021) -
Fr-HMGB1 and ds-HMGB1 activate the kynurenine pathway via different mechanisms in association with depressive-like behavior
por: Wang, Bo, et al.
Publicado: (2019)